[1] |
Ahamad A, Jhingran A. New radiation techniques in gynecological cancer[J]. Int Gynecol Cancer, 2004, 14(3):569-579.
|
[2] |
Vogel WV, Oyen WJ, BarentszJO, et al. PET-CT:panacea,redundary, or something in between?[J]. J Nucl Med, 2004, 45(1S):15-24.
|
[3] |
Bradley JD, Perez CA, Dehdashti F, et al. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer[J]. J Nucl Med, 2004, 45(1S):96-101.
|
[4] |
Brahme A. Recent advances in light ion radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2004, 58(2):603-616.
|
[5] |
Brahme A. Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomographcomputerized tomography imaging[J]. Acta Oncol, 2003, 42(2):123-136.
|
[6] |
Girand P, Grahed D, Montravers F, et al. CT and (18)F-deoxyglucose (FDG)image fusion for optimization of conformal radiotherapy of lung cancer[J]. Int J Radiat Oncol Biol Phys, 2001, 49(5):1249-1257.
|
[7] |
Bradley JD, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer[J]. Int J Radiat Oncol Biol Phys, 2004, 59(1):78-86.
|
[8] |
Mah K, Caldwell C, Ung Y, et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma:a prospective study[J]. Int J Radiat Oncol Biol Phys, 2002, 52(2):339-350.
|
[9] |
Scarfone C, Lavely WC, Cmelak AJ, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaing[J]. J Nucl Med, 2004, 45(4):543-552.
|
[10] |
Ciernik IF, Dizendor E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography(PET-CT):a feasibility study[J]. Int J Radiat Oncol Biol Phys, 2003, 57(3):853-863.
|
[11] |
Czernin J, Phelps ME. Positron emission tomography scanning current and future applications[J]. Annual Rev Med, 2002, 53(2):89-112.
|
[12] |
Weder W, Schmid RA, Bruchhaus H, et al. Detection of extra thoracic metastases by positron emission tomography in lung cancer[J]. Ann Thorac Surg, 1998, 66(3):886-892.
|
[13] |
Dizendort E, Baumert BG, Von Schul-Chess GK, et al. Impact of whole body 18F-FDG PET on staging and managing patients for radiation oncology[J]. J Nucl Med, 2003, 44(1):24-29.
|
[14] |
Leviver M, Massager N, Wikler D, et al. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors:clinical experience and proposed classification[J]. J Nucl Med, 2004,45(7):1146-1154.
|
[15] |
Mutic S, Malyapa RS, Grigsby PW, et al. PET guided IMRT for cervical carcinoma with positive para-aortic lymphnodes:A dose-escalation treatment planning study[J]. Int J Radiat Oncol Biol Phys, 2003,55(1):28-35.
|
[16] |
Esthappan J, Mutic S, Malyapa RS, et al. Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive para-aortic lymphnodes[J]. Int J Radiat Oncol Biol Phys, 2004, 58(4):1289-1297.
|
[17] |
MacManus MP, Hicks RJ, Ball DL, et al. F-18-fluorodexyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung carcinoma:powerful correlation with survival and high impact on treatment[J]. Cancer, 2001, 92(4):886-895.
|